HEADER TRANSFERASE 03-MAY-10 3MV5 TITLE CRYSTAL STRUCTURE OF AKT-1-INHIBITOR COMPLEXES COMPND MOL_ID: 1; COMPND 2 MOLECULE: V-AKT MURINE THYMOMA VIRAL ONCOGENE HOMOLOG 1 (AKT1); COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN; COMPND 5 EC: 2.7.11.1; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: GSK3-BETA PEPTIDE; COMPND 10 CHAIN: C; COMPND 11 FRAGMENT: 10 RESIDUE PEPTIDE FROM GSK3-B (RESIDUES 3-12); COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: AKT-1, AKT1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: SF9; SOURCE 9 MOL_ID: 2; SOURCE 10 SYNTHETIC: YES KEYWDS KINASE INHIBITOR, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.PANDIT REVDAT 3 06-OCT-21 3MV5 1 REMARK SEQADV LINK REVDAT 2 30-MAR-11 3MV5 1 JRNL REVDAT 1 02-JUN-10 3MV5 0 JRNL AUTH K.D.FREEMAN-COOK,C.AUTRY,G.BORZILLO,D.GORDON, JRNL AUTH 2 E.BARBACCI-TOBIN,V.BERNARDO,D.BRIERE,T.CLARK,M.CORBETT, JRNL AUTH 3 J.JAKUBCZAK,S.KAKAR,E.KNAUTH,B.LIPPA,M.J.LUZZIO,M.MANSOUR, JRNL AUTH 4 G.MARTINELLI,M.MARX,K.NELSON,J.PANDIT,F.RAJAMOHAN, JRNL AUTH 5 S.ROBINSON,C.SUBRAMANYAM,L.WEI,M.WYTHES,J.MORRIS JRNL TITL DESIGN OF SELECTIVE, ATP-COMPETITIVE INHIBITORS OF AKT. JRNL REF J.MED.CHEM. V. 53 4615 2010 JRNL REFN ISSN 0022-2623 JRNL PMID 20481595 JRNL DOI 10.1021/JM1003842 REMARK 2 REMARK 2 RESOLUTION. 2.47 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.47 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.92 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.8 REMARK 3 NUMBER OF REFLECTIONS : 14880 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.205 REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.282 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 758 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.47 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.54 REMARK 3 REFLECTION IN BIN (WORKING SET) : 713 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 64.06 REMARK 3 BIN R VALUE (WORKING SET) : 0.2650 REMARK 3 BIN FREE R VALUE SET COUNT : 25 REMARK 3 BIN FREE R VALUE : 0.5080 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2670 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 17 REMARK 3 SOLVENT ATOMS : 56 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.12 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.22000 REMARK 3 B22 (A**2) : -0.03000 REMARK 3 B33 (A**2) : 1.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.51000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.316 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.233 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 10.355 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.934 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.879 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2758 ; 0.023 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3714 ; 2.186 ; 1.975 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 325 ; 7.749 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 135 ;38.800 ;23.333 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 496 ;19.726 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 20 ;20.739 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 387 ; 0.136 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2091 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1214 ; 0.235 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1833 ; 0.318 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 108 ; 0.147 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 23 ; 0.130 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 5 ; 0.154 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1676 ; 1.073 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2613 ; 1.825 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1252 ; 2.800 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1101 ; 4.122 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3MV5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-MAY-10. REMARK 100 THE DEPOSITION ID IS D_1000059032. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E+ DW REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : VARI-MAX OPTICS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS HTC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : D*TREK REMARK 200 DATA SCALING SOFTWARE : D*TREK 8.0SSI REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14895 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.470 REMARK 200 RESOLUTION RANGE LOW (A) : 90.540 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.0 REMARK 200 DATA REDUNDANCY : 3.130 REMARK 200 R MERGE (I) : 0.08200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.47 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.56 REMARK 200 COMPLETENESS FOR SHELL (%) : 72.7 REMARK 200 DATA REDUNDANCY IN SHELL : 2.68 REMARK 200 R MERGE FOR SHELL (I) : 0.33100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.23 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.63 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 27.70850 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1450 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15080 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -6.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 139 REMARK 465 ALA A 140 REMARK 465 MET A 141 REMARK 465 ASP A 142 REMARK 465 PRO A 143 REMARK 465 THR A 448 REMARK 465 ILE A 449 REMARK 465 THR A 450 REMARK 465 PRO A 451 REMARK 465 PRO A 452 REMARK 465 ASP A 453 REMARK 465 GLN A 454 REMARK 465 ASP A 455 REMARK 465 ASP A 456 REMARK 465 SER A 457 REMARK 465 MET A 458 REMARK 465 GLU A 459 REMARK 465 CYS A 460 REMARK 465 VAL A 461 REMARK 465 ASP A 462 REMARK 465 SER A 463 REMARK 465 GLU A 464 REMARK 465 ARG A 465 REMARK 465 SER A 478 REMARK 465 THR A 479 REMARK 465 ALA A 480 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 ARG A 243 CG ARG A 243 CD 0.152 REMARK 500 TYR A 350 CZ TYR A 350 CE2 0.086 REMARK 500 TYR A 350 CE2 TYR A 350 CD2 0.134 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 325 CB - CG - OD1 ANGL. DEV. = 6.0 DEGREES REMARK 500 ARG A 328 NE - CZ - NH2 ANGL. DEV. = -3.7 DEGREES REMARK 500 TYR A 350 CB - CG - CD2 ANGL. DEV. = 4.0 DEGREES REMARK 500 TYR A 350 CB - CG - CD1 ANGL. DEV. = -4.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 153 -68.92 -105.11 REMARK 500 ASP A 190 24.84 82.48 REMARK 500 THR A 211 112.74 -36.22 REMARK 500 ARG A 243 -51.93 77.67 REMARK 500 ARG A 273 -21.62 75.30 REMARK 500 ASP A 292 106.15 55.61 REMARK 500 ASP A 302 -146.97 55.54 REMARK 500 ARG A 370 0.13 -67.06 REMARK 500 ASP A 398 -129.33 52.03 REMARK 500 THR A 435 35.74 -84.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MN A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE XFE A 999 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3CQU RELATED DB: PDB REMARK 900 RELATED ID: 3CQW RELATED DB: PDB REMARK 900 RELATED ID: 3MVH RELATED DB: PDB REMARK 900 RELATED ID: 3MVJ RELATED DB: PDB DBREF 3MV5 A 144 480 UNP B2RAM5 B2RAM5_HUMAN 144 480 DBREF 3MV5 C 1 10 PDB 3MV5 3MV5 1 10 SEQADV 3MV5 GLY A 139 UNP B2RAM5 EXPRESSION TAG SEQADV 3MV5 ALA A 140 UNP B2RAM5 EXPRESSION TAG SEQADV 3MV5 MET A 141 UNP B2RAM5 EXPRESSION TAG SEQADV 3MV5 ASP A 142 UNP B2RAM5 EXPRESSION TAG SEQADV 3MV5 PRO A 143 UNP B2RAM5 EXPRESSION TAG SEQADV 3MV5 ASP A 473 UNP B2RAM5 SER 473 ENGINEERED MUTATION SEQRES 1 A 342 GLY ALA MET ASP PRO ARG VAL THR MET ASN GLU PHE GLU SEQRES 2 A 342 TYR LEU LYS LEU LEU GLY LYS GLY THR PHE GLY LYS VAL SEQRES 3 A 342 ILE LEU VAL LYS GLU LYS ALA THR GLY ARG TYR TYR ALA SEQRES 4 A 342 MET LYS ILE LEU LYS LYS GLU VAL ILE VAL ALA LYS ASP SEQRES 5 A 342 GLU VAL ALA HIS THR LEU THR GLU ASN ARG VAL LEU GLN SEQRES 6 A 342 ASN SER ARG HIS PRO PHE LEU THR ALA LEU LYS TYR SER SEQRES 7 A 342 PHE GLN THR HIS ASP ARG LEU CYS PHE VAL MET GLU TYR SEQRES 8 A 342 ALA ASN GLY GLY GLU LEU PHE PHE HIS LEU SER ARG GLU SEQRES 9 A 342 ARG VAL PHE SER GLU ASP ARG ALA ARG PHE TYR GLY ALA SEQRES 10 A 342 GLU ILE VAL SER ALA LEU ASP TYR LEU HIS SER GLU LYS SEQRES 11 A 342 ASN VAL VAL TYR ARG ASP LEU LYS LEU GLU ASN LEU MET SEQRES 12 A 342 LEU ASP LYS ASP GLY HIS ILE LYS ILE THR ASP PHE GLY SEQRES 13 A 342 LEU CYS LYS GLU GLY ILE LYS ASP GLY ALA THR MET LYS SEQRES 14 A 342 TPO PHE CYS GLY THR PRO GLU TYR LEU ALA PRO GLU VAL SEQRES 15 A 342 LEU GLU ASP ASN ASP TYR GLY ARG ALA VAL ASP TRP TRP SEQRES 16 A 342 GLY LEU GLY VAL VAL MET TYR GLU MET MET CYS GLY ARG SEQRES 17 A 342 LEU PRO PHE TYR ASN GLN ASP HIS GLU LYS LEU PHE GLU SEQRES 18 A 342 LEU ILE LEU MET GLU GLU ILE ARG PHE PRO ARG THR LEU SEQRES 19 A 342 GLY PRO GLU ALA LYS SER LEU LEU SER GLY LEU LEU LYS SEQRES 20 A 342 LYS ASP PRO LYS GLN ARG LEU GLY GLY GLY SER GLU ASP SEQRES 21 A 342 ALA LYS GLU ILE MET GLN HIS ARG PHE PHE ALA GLY ILE SEQRES 22 A 342 VAL TRP GLN HIS VAL TYR GLU LYS LYS LEU SER PRO PRO SEQRES 23 A 342 PHE LYS PRO GLN VAL THR SER GLU THR ASP THR ARG TYR SEQRES 24 A 342 PHE ASP GLU GLU PHE THR ALA GLN MET ILE THR ILE THR SEQRES 25 A 342 PRO PRO ASP GLN ASP ASP SER MET GLU CYS VAL ASP SER SEQRES 26 A 342 GLU ARG ARG PRO HIS PHE PRO GLN PHE ASP TYR SER ALA SEQRES 27 A 342 SER SER THR ALA SEQRES 1 C 10 GLY ARG PRO ARG THR THR SER PHE ALA GLU MODRES 3MV5 TPO A 308 THR PHOSPHOTHREONINE HET TPO A 308 11 HET MN A 1 1 HET XFE A 999 16 HETNAM TPO PHOSPHOTHREONINE HETNAM MN MANGANESE (II) ION HETNAM XFE (3R)-1-(5-METHYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL) HETNAM 2 XFE PYRROLIDIN-3-AMINE HETSYN TPO PHOSPHONOTHREONINE FORMUL 1 TPO C4 H10 N O6 P FORMUL 3 MN MN 2+ FORMUL 4 XFE C11 H15 N5 FORMUL 5 HOH *56(H2 O) HELIX 1 1 THR A 146 ASN A 148 5 3 HELIX 2 2 LYS A 183 LYS A 189 1 7 HELIX 3 3 GLU A 191 ASN A 204 1 14 HELIX 4 4 GLU A 234 ARG A 243 1 10 HELIX 5 5 SER A 246 ASN A 269 1 24 HELIX 6 6 LYS A 276 GLU A 278 5 3 HELIX 7 7 THR A 312 LEU A 316 5 5 HELIX 8 8 ALA A 317 GLU A 322 1 6 HELIX 9 9 ALA A 329 GLY A 345 1 17 HELIX 10 10 ASP A 353 GLU A 364 1 12 HELIX 11 11 GLY A 373 LEU A 384 1 12 HELIX 12 12 ASP A 398 GLN A 404 1 7 HELIX 13 13 HIS A 405 ALA A 409 5 5 HELIX 14 14 VAL A 412 LYS A 419 1 8 HELIX 15 15 ASP A 439 ALA A 444 1 6 SHEET 1 A 6 PHE A 150 LYS A 158 0 SHEET 2 A 6 GLY A 162 GLU A 169 -1 O VAL A 164 N GLY A 157 SHEET 3 A 6 TYR A 175 LYS A 182 -1 O TYR A 176 N VAL A 167 SHEET 4 A 6 ARG A 222 MET A 227 -1 O LEU A 223 N LEU A 181 SHEET 5 A 6 LEU A 213 GLN A 218 -1 N TYR A 215 O VAL A 226 SHEET 6 A 6 TYR A 474 SER A 475 -1 O TYR A 474 N SER A 216 SHEET 1 B 2 LEU A 280 LEU A 282 0 SHEET 2 B 2 ILE A 288 ILE A 290 -1 O LYS A 289 N MET A 281 SHEET 1 C 2 CYS A 310 GLY A 311 0 SHEET 2 C 2 PHE C 8 ALA C 9 -1 O PHE C 8 N GLY A 311 LINK C LYS A 307 N TPO A 308 1555 1555 1.33 LINK C TPO A 308 N PHE A 309 1555 1555 1.35 LINK MN MN A 1 OE2 GLU A 314 1555 1555 2.58 SITE 1 AC1 2 GLU A 314 HIS A 354 SITE 1 AC2 9 HOH A 51 ALA A 177 MET A 227 GLU A 228 SITE 2 AC2 9 ALA A 230 GLU A 234 GLU A 278 MET A 281 SITE 3 AC2 9 PHE A 438 CRYST1 42.706 55.417 93.287 90.00 104.00 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023416 0.000000 0.005836 0.00000 SCALE2 0.000000 0.018045 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011048 0.00000